Systemic Inflammatory Markers for Predicting Overall Survival in Patients with Osteosarcoma: A Systematic Review and Meta-Analysis.

Xiaotong SongHao ZhangFanxing YinPanpan GuoXiaocheng YangJinzhu LiuYanshou Han Zhaozhou Ren

Published in: Mediators of inflammation (2021)

Worsened prognosis may be related to high levels of NLR, CRP, and GPS before treatment rather than LMR or PLR, which can provide the basis for clinicians to judge the outcomes of prognosis. Trial Registration. PROSPERO (CRD42021249954), https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=249954.

Keyphrases

clinical trial
palliative care
phase iii
cross sectional
randomized controlled trial
phase ii
combination therapy
insulin resistance
adipose tissue
free survival
skeletal muscle
smoking cessation